generated: '2026-08-23'
method: derived
source: >-
  openapi/jnana-therapeutics-content-openapi.yml plus live probes of www.jnanatx.com on 2026-08-23.
  Searched the site for a status page, changelog, SLA, versioning policy and deprecation policy;
  none exists.
summary: >-
  Jnana Therapeutics publishes no API lifecycle commitments of any kind, because it publishes no
  API. The content surface catalogued here is versioned only by the WordPress namespace convention
  it inherits, and carries no announced support window.
versioning:
  scheme: namespace-in-path
  current: wp/v2
  previous: []
  policy_published: false
  policy_url: null
  note: >-
    `wp/v2` is upstream WordPress core versioning, not a Jnana commitment. A future WordPress major
    could introduce wp/v3 without any notice from this provider.
deprecation:
  policy_published: false
  policy_url: null
  sunset_header: false
  deprecation_header: false
  rfc8594: false
  deprecated_operations: []
  note: >-
    No RFC 8594 Sunset or Deprecation header was present on any observed response, and no operation
    in the derived OpenAPI is marked deprecated. One route that WordPress core normally registers —
    /wp/v2/tags — is simply absent (404 rest_no_route) rather than deprecated.
status_page:
  published: false
  url: null
  note: >-
    No status.jnanatx.com, no status page linked from the site, and no third-party status provider
    referenced. The deployment runs on WP Engine behind Cloudflare; neither vendor status page is a
    Jnana commitment and neither is claimed here.
sla:
  published: false
  url: null
changelog:
  published: false
  url: null
  note: >-
    The /news/ archive is corporate press-release news, not an API changelog. It is wired in
    apis.yml as `News` and `BlogRSS`, not as ChangeLog.
support:
  developer_support: none
  general_contact: info@jnanatx.com
  contact_page: https://www.jnanatx.com/contact-us/
  note: General corporate inquiries only. There is no developer support channel.
corporate_lifecycle:
  status: acquired-operating-subsidiary
  parent: Otsuka America, Inc. (a wholly owned subsidiary of Otsuka Pharmaceutical Co., Ltd.)
  acquisition_completed: '2024-09-23'
  source: https://www.jnanatx.com/otsuka-pharmaceutical-completes-acquisition-of-jnana-therapeutics-inc/
  note: >-
    Recorded because it is the strongest available signal about the future of this surface: the
    brand still publishes under its own domain and posted news as recently as 2026-02-24, but the
    company is a subsidiary and the domain could be folded into the parent without notice.
  latest_post_at_harvest: '2026-02-24'
evidence:
- url: https://www.jnanatx.com/wp-json/wp/v2/posts?per_page=1
  status: 200
  note: 'No Sunset, Deprecation or Link rel="sunset" header present.'
- url: https://www.jnanatx.com/wp-json/wp/v2/tags?per_page=1
  status: 404
  note: rest_no_route — route absent, not deprecated.
- url: https://www.jnanatx.com/.well-known/security.txt
  status: 404